Merck And Co

Merck And Co, a US-based Pharmaceutical Preparation Manufacturing company, reported its carbon emissions for 2024. The company's total emissions for 2024 were approximately 6.94 billion kg CO2e. This included Scope 1 emissions of 721.2 million kg CO2e, market-based Scope 2 emissions of 163 million kg CO2e, and Scope 3 emissions of approximately 6.06 billion kg CO2e.

Looking back, Merck And Co's total emissions have fluctuated. In 2023, the total emissions were approximately 6.76 billion kg CO2e, with Scope 1 at 731.6 million kg CO2e, market-based Scope 2 at 170.1 million kg CO2e, and Scope 3 at approximately 5.86 billion kg CO2e. In 2022, total emissions stood at approximately 6.96 billion kg CO2e, comprising 739.5 million kg CO2e for Scope 1, 217.3 million kg CO2e for market-based Scope 2, and approximately 6 billion kg CO2e for Scope 3.

Merck And Co has committed to several ambitious climate targets. The company aims to achieve net-zero greenhouse gas (GHG) emissions across its global operations (Scopes 1, 2, and 3) by 2045, a target aligned with the Science Based Targets initiative (SBTi). For near-term reductions, Merck And Co has committed to reducing its absolute Scope 1 and 2 GHG emissions by 46% by 2030, using a 2019 baseline. Furthermore, the company plans to reduce its absolute Scope 3 GHG emissions by 30% within the same timeframe (2019 baseline to 2030). Merck And Co has also set a goal to become carbon neutral across its operations (Scopes 1 and 2 GHG emissions) by 2025.